AGIOS PHARMACEUTICALS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-314.7M | $-198.5M | $-117.7M | $-53.5M | $-39.4M | $-20.1M | $-23.7M |
| Depreciation & Amortization | $6.4M | — | — | — | — | — | — |
| Depreciation | $6.4M | $5.7M | $3.3M | $1.4M | $1.4M | $1.2M | $801.0K |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $47.8M | $42.1M | $32.0M | $11.5M | $3.0M | $742.0K | $371.0K |
| Net Cash from Operating Activities | $-285.2M | $38.6M | $-76.9M | $-59.4M | $-56.4M | $-49.5M | $-15.2M |
| Investing Activities | |||||||
| Capital Expenditures | $4.6M | $9.9M | $20.2M | $2.2M | $1.3M | $1.5M | $1.9M |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-57.9M | $-119.4M | $128.3M | — | $-87.2M | $23.0M | $-22.4M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $285.1M | $169.8M | $6.4M | — | $123.9M | $142.0K | $77.4M |
| Net Change in Cash | $-58.0M | $89.0M | $57.7M | $-57.5M | $-19.7M | $-26.4M | $39.8M |
| Free Cash Flow | $-289.9M | $28.6M | $-97.1M | $-61.6M | $-57.7M | $-51.0M | $-17.1M |